ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,781Medicare Part D Prescriptions Filled, Including Refills

Rank: 350 out of 6645

$1.45M Total Retail Price of All Prescriptions

Rank: 144 out of 6645

774 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 774 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

21% of this provider’s 774 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

3% of this provider’s 11,519 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$98 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
HYDROCODONE-ACETAMINOPHEN 686 484 S3 1 5
LEVOTHYROXINE SODIUM 540 476 2 4
SIMVASTATIN 499 441 3 1
ZOLPIDEM TARTRATE 387 309 4 17
OMEPRAZOLE 385 289 5 6
LISINOPRIL 347 325 6 3
LOSARTAN POTASSIUM 346 317 7 12
AMLODIPINE BESYLATE 341 294 8 2
HYDROCHLOROTHIAZIDE 330 290 9 9
MELOXICAM 296 234 10 46
METFORMIN HCL 284 247 11 7
ATENOLOL 252 206 12 8
TAMSULOSIN HCL 240 231 13 22
FUROSEMIDE 226 191 14 11
GABAPENTIN 179 88 15 18
PANTOPRAZOLE SODIUM 166 124 16 29
LOVASTATIN 158 153 17 15
ATORVASTATIN CALCIUM 151 116 18 10
SERTRALINE HCL 151 133 18 43
METOPROLOL TARTRATE 144 109 20 13
GLIMEPIRIDE 137 126 21 47
PREMARIN 130 103 R 22 169
ALLOPURINOL 126 116 23 31
DIGOXIN 123 116 24 59
CLOPIDOGREL 121 104 25 36
FLUOXETINE HCL 117 75 26 63
LOSARTAN-HYDROCHLOROTHIAZIDE 114 110 27 62
TRAZODONE HCL 110 73 28 60
CARVEDILOL 107 97 29 25
ADVAIR DISKUS 102 81 30 45
METOPROLOL SUCCINATE 100 63 31 24
BYSTOLIC 99 70 32 110
PLAVIX 93 87 33 49
MIRTAZAPINE 90 76 34 70
CLONIDINE HCL 89 71 35 56
NEXIUM 81 35 36 40
WARFARIN SODIUM 79 64 37 16
LEVOFLOXACIN 78 60 38 83
ESTRADIOL 76 57 R 39 165
DIPHENOXYLATE-ATROPINE 75 62 40 214
TERAZOSIN HCL 74 65 41 48
PREDNISONE 73 59 42 57
POTASSIUM CHLORIDE 72 59 43 28
CITALOPRAM HBR 70 65 44 35
DIOVAN 69 59 45 19
SPIRIVA 69 48 45 65
ALPRAZOLAM 68 57 47 195
PRAVASTATIN SODIUM 67 54 48 20
VIREAD 66 42 49 259
CYMBALTA 64 55 50 78
DOXAZOSIN MESYLATE 62 47 51 81
FLUCONAZOLE 62 45 51 298
ZETIA 61 47 53 87
BENAZEPRIL HCL 59 45 54 21
ATRIPLA 59 17 54 254
BUPROPION HCL SR 59 23 54 296
TRUVADA 59 0 54 135
VERAPAMIL ER 57 47 58 154
VIRAMUNE XR 57 0 58 371
TRAMADOL HCL 57 38 58 30
EXFORGE 57 45 58 155
PROAIR HFA 57 41 58 32
LORAZEPAM 56 49 63 189
CRESTOR 54 54 64 34
IBUPROFEN 53 33 65 42
FINASTERIDE 53 49 65 73
TIZANIDINE HCL 51 23 67 290
TRICOR 51 24 67 138
DICYCLOMINE HCL 50 49 69 278
CARISOPRODOL 50 13 R 69 94
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 28, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.